NEW YORK, May 19 (GenomeWeb News) - Solexa announced yesterday that it is trying to obtain permission from the US Securities and Exchange Commission to issue $100 million worth of securities, which may consist of common stock, preferred stock, warrants, debt, or any combination thereof.
Registering provides access to this and other free content.
Already have an account?Login Now.
Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.
Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.
The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.
In Science this week: genetically modified flu virus could be key to new live vaccines, and more.